The FDA approved pre‑exposure prophylaxis (PrEP) in 2012.
2012-01-01 → 2013-01-01
Standing
lens: Evidence-weighted Structural
No belief has been computed for this claim under Evidence-weighted yet.
What bears on it
Nothing supports or challenges this claim yet — untested, which is not the same as refuted.
Voices
- EATG independent
Voices are counted, never weighed. How many people say a thing is structure worth seeing; it is not, by itself, a reason to believe it.
What the documents actually said
The verbatim text each extraction read before resolving it into this canonical claim. Quoted, never republished.
- The FDA approved pre‑exposure prophylaxis (PrEP) in 2012.
In 2012, the FDA approved pre‑exposure prophylaxis (PrEP), an antiviral drug taken once a day that is highly successful at preventing new HIV infections.
Sources
Who and what it involves
Origin: extracted from Trump makes sweeping HIV research and grant cuts: ‘setting us back decades’ · 2026-09-11 22:10